ENTITY
Cathay Biotech

Cathay Biotech (688065 CH)

39
Analysis
MaterialsChina
Cathay Biotech Inc. engages in synthetic biology, producing new materials on an industrial scale through bio-manufacturing. The Company focuses on polyamide industry's value chain covering biological long-chain dibasic acid, bio-based pentane diamine, bio-based polyamide, and more. Cathay Biotech markets its products worldwide.
more
bullishSG Micro
04 May 2022 07:56

CSI300 Index Rebalance Preview: 30 Potential Changes as Sector Rotation Continues

We forecast 30 changes at the June rebalance for the CSI300 Index - most high probability. Industrials, IT and Materials sectors will have net...

Logo
851 Views
Share
06 Apr 2022 04:57

CSI300 Index Rebalance Preview (June): Maxing Out the 30 Changes

We estimate 30 changes at the June rebalance with a one-way turnover of 4.48% leading to a one-way trade of CNY 7.86bn. The potential adds have...

Logo
609 Views
Share
bullishTBEA Co Ltd A
17 Jan 2022 07:10

CSI300 Index Rebalance Preview (June 2022): Changes Near the Midway Mark

Nearly midway through the review period for the June rebalance of the CSI300 index, we see 29 potential changes resulting in a one-way turnover of...

Logo
738 Views
Share
bullishCathay Biotech
29 May 2021 17:05

STAR Board - STAR50 Index Rebalance: Inclusions Outperform Exclusions as Positioning Jumps

There are 5 changes to the STAR50 Index at the June review. The inclusions have outperformed the deletions and positioning has jumped sharply in...

Logo
530 Views
Share
bullishNinebot
21 Apr 2021 09:59

STAR Board - STAR50 Index Rebalance June Preview: Falling Volumes Increasing Impact

We see 5 changes to the STAR50 Index at the June review. The deletions are high probability, but there is uncertainty on the inclusions due to a...

Logo
561 Views
Share
x